Cargando…

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection

Recurrent Clostridium difficile infection represents a burdensome clinical issue whose epidemiology is increasing worldwide. The pathogenesis is not yet completely known. Recent observations suggest that the alteration of the intestinal microbiota and impaired innate immunity may play a leading role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bibbò, Stefano, Lopetuso, Loris Riccardo, Ianiro, Gianluca, Di Rienzo, Teresa, Gasbarrini, Antonio, Cammarota, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068057/ https://www.ncbi.nlm.nih.gov/pubmed/24995345 http://dx.doi.org/10.1155/2014/462740

Ejemplares similares

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)

Prior Misdiagnosis of Celiac Disease Is Common Among Patients Referred to a Tertiary Care Center: A Prospective Cohort Study
por: Ianiro, Gianluca, et al.
Publicado: (2016)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Gut microbiota and immunotherapy of renal cell carcinoma
por: Bibbò, Stefano, et al.
Publicado: (2023)

“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
por: Del Vecchio, Livio Enrico, et al.
Publicado: (2022)

Role of gut microbiome on immunotherapy efficacy in melanoma
por: Bibbò, Stefano, et al.
Publicado: (2021)

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
por: Bibbò, Stefano, et al.
Publicado: (2018)

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
por: Rinninella, Emanuele, et al.
Publicado: (2020)

COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
por: Settanni, Carlo Romano, et al.
Publicado: (2021)

The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
por: Cianci, Rossella, et al.
Publicado: (2019)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota
por: Fiorani, Marcello, et al.
Publicado: (2023)

Microbiota Composition in Diverticular Disease: Implications for Therapy
por: Tursi, Antonio, et al.
Publicado: (2022)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018)

Digestive Enzyme Supplementation in Gastrointestinal Diseases
por: Ianiro, Gianluca, et al.
Publicado: (2016)

Gut Microbiota Profiling and Gut–Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
por: Quagliariello, Andrea, et al.
Publicado: (2018)

Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
por: Piccioni, Andrea, et al.
Publicado: (2022)

Humanized microbiota mice as a model of recurrent Clostridium difficile disease
por: Collins, James, et al.
Publicado: (2015)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Song, Yang, et al.
Publicado: (2013)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
por: Airola, Carlo, et al.
Publicado: (2023)

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018)

Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)

Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018)

Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022)

Correction: Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Publicado: (2014)

Tea and Recurrent Clostridium difficile Infection
por: Oman Evans II, Martin, et al.
Publicado: (2016)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_21kgmeislpqv478ueuus1g05fa